AstraZeneca (AZN) News Today $70.96 +0.55 (+0.78%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$70.70 -0.26 (-0.36%) As of 04:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Polar Asset Management Partners Inc. Takes Position in AstraZeneca PLC (NASDAQ:AZN)Polar Asset Management Partners Inc. bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 194,800 shares of the company's stMay 27 at 7:08 AM | marketbeat.comMackenzie Financial Corp Raises Stake in AstraZeneca PLC (NASDAQ:AZN)Mackenzie Financial Corp raised its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 73.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 530,037 shares of the company's stock after buyingMay 27 at 5:15 AM | marketbeat.comSunbelt Securities Inc. Purchases 3,885 Shares of AstraZeneca PLC (NASDAQ:AZN)Sunbelt Securities Inc. raised its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 50.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,625 shares of the company's stocMay 27 at 5:05 AM | marketbeat.comTwo Sigma Advisers LP Acquires Shares of 86,100 AstraZeneca PLC (NASDAQ:AZN)Two Sigma Advisers LP bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 86,100 shares of the company's stock, valued at approximately $5,May 27 at 4:27 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Given Average Recommendation of "Buy" by BrokeragesAstraZeneca PLC (NASDAQ:AZN - Get Free Report) has been assigned an average recommendation of "Buy" from the ten ratings firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and two have gMay 27 at 1:32 AM | marketbeat.comGF Fund Management CO. LTD. Invests $8.03 Million in AstraZeneca PLC (NASDAQ:AZN)GF Fund Management CO. LTD. purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 122,586 shares of the company'sMay 26 at 6:08 AM | marketbeat.comVoloridge Investment Management LLC Sells 251,756 Shares of AstraZeneca PLC (NASDAQ:AZN)Voloridge Investment Management LLC lessened its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 56.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 196,661 shares of the compaMay 26 at 4:45 AM | marketbeat.comToronto Dominion Bank Buys 9,151 Shares of AstraZeneca PLC (NASDAQ:AZN)Toronto Dominion Bank raised its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 51.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 27,080 shares of the company's stock after purchasing an additional 9,151 shares during the quarter. Toronto DominioMay 26 at 4:16 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Receives Consensus Rating of "Buy" from BrokeragesMay 26 at 1:35 AM | americanbankingnews.comZacks Research Increases Earnings Estimates for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Stock analysts at Zacks Research upped their Q2 2026 earnings per share (EPS) estimates for AstraZeneca in a research note issued to investors on Tuesday, May 20th. Zacks Research analyst R. Department now anticipates that the company will post earningMay 25 at 8:20 AM | marketbeat.com26,048 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Parr Mcknight Wealth Management Group LLCParr Mcknight Wealth Management Group LLC bought a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 26,048 shares of the company's stock, valued at approximatelyMay 25 at 7:39 AM | marketbeat.comWhy AstraZeneca May Be 2025's Most Underrated Pharma StockMay 25 at 5:01 AM | seekingalpha.comWaverly Advisors LLC Acquires 15,881 Shares of AstraZeneca PLC (NASDAQ:AZN)Waverly Advisors LLC raised its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 191.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 24,155 shares of the company's stock after acqMay 25 at 4:42 AM | marketbeat.comZacks Research Lowers Earnings Estimates for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Research analysts at Zacks Research reduced their Q2 2025 earnings per share (EPS) estimates for shares of AstraZeneca in a report released on Tuesday, May 20th. Zacks Research analyst R. Department now expects that the company will post earnings of $1May 24, 2025 | marketbeat.comNuveen Asset Management LLC Sells 1,780,358 Shares of AstraZeneca PLC (NASDAQ:AZN)Nuveen Asset Management LLC decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 78.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 475,222 shares of the cMay 24, 2025 | marketbeat.comQ2 EPS Estimates for AstraZeneca Increased by Zacks ResearchMay 24, 2025 | americanbankingnews.comQ2 EPS Estimates for AstraZeneca Decreased by Zacks ResearchMay 24, 2025 | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP trimmed its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 39.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 661,670 shares of the company's stock after selling 437,786 shMay 23, 2025 | marketbeat.comPrincipal Street Partners LLC Lowers Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Principal Street Partners LLC lessened its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 50.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,914 shares of the company's stock afterMay 22, 2025 | marketbeat.comVestal Point Capital LP Purchases New Holdings in AstraZeneca PLC (NASDAQ:AZN)Vestal Point Capital LP acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 475,000 shares of the company's stock, valued at approximately $31,122,000. AstrMay 21, 2025 | marketbeat.comSoleus Capital Management L.P. Purchases Shares of 409,000 AstraZeneca PLC (NASDAQ:AZN)Soleus Capital Management L.P. acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 409,000 shares of the company's stock, valued at approximMay 21, 2025 | marketbeat.comRoyal Bank of Canada Lowers Holdings in AstraZeneca PLC (NASDAQ:AZN)Royal Bank of Canada reduced its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,432,811 shares of the company's stock after selling 58,380 shares during the period. Royal Bank of CanadaMay 21, 2025 | marketbeat.com3 Promising Growth Stocks You Can Buy for Less Than $100May 20, 2025 | fool.comHow Does D-Wave Stack Up Against Quantum Competitors? (AZN)D-Wave, IonQ, and Rigetti are three of the most talked-about quantum computing firms; how do these three companies stack up against one another?May 20, 2025 | marketbeat.comTexas Bank & Trust Co Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)Texas Bank & Trust Co purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 16,022 shares of the company's stock, valued at approximately $1,050,000. SevMay 20, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Strategic Wealth Partners Ltd.Strategic Wealth Partners Ltd. raised its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 62.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 158,945 shares of the company's stock after acquiring an additional 61,259 shares during the period. StrMay 20, 2025 | marketbeat.comThornburg Investment Management Inc. Acquires 19,496 Shares of AstraZeneca PLC (NASDAQ:AZN)Thornburg Investment Management Inc. boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 505,522 shares of the company's stock afterMay 20, 2025 | marketbeat.comAstraZeneca PLC (AZN) Trial: Airsupra Cuts Severe Asthma Risk by 47%May 19, 2025 | insidermonkey.comStatistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthmaMay 19, 2025 | businesswire.comSilvercrest Asset Management Group LLC Has $18.87 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Silvercrest Asset Management Group LLC increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 43.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 288,071 shares of the company's stock aftMay 19, 2025 | marketbeat.comRafferty Asset Management LLC Buys 46,918 Shares of AstraZeneca PLC (NASDAQ:AZN)Rafferty Asset Management LLC lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 31.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 196,657 shares of the company's stockMay 19, 2025 | marketbeat.comNissay Asset Management Corp Japan ADV Purchases 7,008 Shares of AstraZeneca PLC (NASDAQ:AZN)Nissay Asset Management Corp Japan ADV boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 59,213 shares of the company's stockMay 19, 2025 | marketbeat.comDeutsche Bank AG Buys 6,039 Shares of AstraZeneca PLC (NASDAQ:AZN)Deutsche Bank AG increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 164,624 shares of the company's stock after acquiringMay 19, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Sphera Funds Management LTD.Sphera Funds Management LTD. raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 225,060 shares of the company's stock after acquirMay 18, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by ProShare Advisors LLCProShare Advisors LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 688,182 shares of the company's stock after buying aMay 18, 2025 | marketbeat.comQuantinno Capital Management LP Lowers Stock Position in AstraZeneca PLC (NASDAQ:AZN)Quantinno Capital Management LP decreased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 115,100 shares of the company's stock after selliMay 18, 2025 | marketbeat.comNomura Holdings Inc. Sells 127,159 Shares of AstraZeneca PLC (NASDAQ:AZN)Nomura Holdings Inc. lowered its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 65.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 68,221 shares of the company's stock after selling 127,159 shares duMay 18, 2025 | marketbeat.comPolar Asset Management Partners Inc. Invests $12.76 Million in AstraZeneca PLC (NASDAQ:AZN)Polar Asset Management Partners Inc. acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 194,800 shares of the company's stock, vaMay 17, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Pathstone Holdings LLCPathstone Holdings LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 370,229 shares of the compMay 17, 2025 | marketbeat.comGraham Capital Management L.P. Has $664,000 Position in AstraZeneca PLC (NASDAQ:AZN)Graham Capital Management L.P. cut its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 50.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,139 shares of the company's stock after selling 10,259 shares duringMay 17, 2025 | marketbeat.comFocus Partners Wealth Has $4.59 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Focus Partners Wealth boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 69,067 shares of the company's stock after buying an additionaMay 17, 2025 | marketbeat.comParkwood LLC Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)Parkwood LLC lifted its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 62.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 118,199 shares of the company's stock after purchasing an additional 45,514 sharMay 16, 2025 | marketbeat.comRep. Bruce Westerman Sells AstraZeneca PLC (NASDAQ:AZN) SharesRepresentative Bruce Westerman (R-Arkansas) recently sold shares of AstraZeneca PLC (NASDAQ:AZN). In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in AstraZeneca stock on April 21st. The trade occurred in the Representative's "FISHER IRA"May 16, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 458,631 shares of the company's stock after selling 10,936 shares during the quMay 16, 2025 | marketbeat.comBernstein Remains a Buy on AstraZeneca (AZN)May 15, 2025 | theglobeandmail.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $4.03 Million Investment in AstraZeneca PLC (NASDAQ:AZN)OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 61,447 shares oMay 15, 2025 | marketbeat.comLazard Asset Management LLC Trims Stock Position in AstraZeneca PLC (NASDAQ:AZN)Lazard Asset Management LLC cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 20.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 918,666 shares of the company's stock after selling 242,203May 15, 2025 | marketbeat.comJanus Henderson Group PLC Purchases 374,705 Shares of AstraZeneca PLC (NASDAQ:AZN)Janus Henderson Group PLC grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 22.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,044,259 shares of the company's stock after buying an additMay 15, 2025 | marketbeat.comLaird Norton Wetherby Wealth Management LLC Sells 7,493 Shares of AstraZeneca PLC (NASDAQ:AZN)Laird Norton Wetherby Wealth Management LLC reduced its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 69,577 shares of the company's stock after sellinMay 14, 2025 | marketbeat.comIntegral Health Asset Management LLC Acquires New Stake in AstraZeneca PLC (NASDAQ:AZN)Integral Health Asset Management LLC acquired a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 225,000 shares of the company's stock,May 14, 2025 | marketbeat.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼1.201.03▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼2925▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts